Andy Robling is currently the Oncology Portfolio Director at Amgen, where they have held various marketing roles since 2016, including positions as Marketing Director for both Oncology NSCLC and Patient Access & Reimbursement. Prior to their tenure at Amgen, they worked as a Financial Advisor at German American Investments from 2005 to 2012. Andy is also pursuing a degree in Finance at the University of Evansville.
This person is not in the org chart
This person is not in any teams
This person is not in any offices